Anti-STIL monoclonal antibody

Pre-made anti-STIL monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to STIL/STIL products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2758-Ab-1/ GM-Tg-hg-IP2758-Ab-2Anti-Human STIL monoclonal antibodyHuman
GM-Tg-rg-IP2758-Ab-1/ GM-Tg-rg-IP2758-Ab-2Anti-Rat STIL monoclonal antibodyRat
GM-Tg-mg-IP2758-Ab-1/ GM-Tg-mg-IP2758-Ab-2Anti-Mouse STIL monoclonal antibodyMouse
GM-Tg-cynog-IP2758-Ab-1/ GM-Tg-cynog-IP2758-Ab-2Anti-Cynomolgus/ Rhesus macaque STIL monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2758-Ab-1/ GM-Tg-felg-IP2758-Ab-2Anti-Feline STIL monoclonal antibodyFeline
GM-Tg-cang-IP2758-Ab-1/ GM-Tg-cang-IP2758-Ab-2Anti-Canine STIL monoclonal antibodyCanine
GM-Tg-bovg-IP2758-Ab-1/ GM-Tg-bovg-IP2758-Ab-2Anti-Bovine STIL monoclonal antibodyBovine
GM-Tg-equg-IP2758-Ab-1/ GM-Tg-equg-IP2758-Ab-2Anti-Equine STIL monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2758-Ab-1/ GM-Tg-hg-IP2758-Ab-2; GM-Tg-rg-IP2758-Ab-1/ GM-Tg-rg-IP2758-Ab-2;
GM-Tg-mg-IP2758-Ab-1/ GM-Tg-mg-IP2758-Ab-2; GM-Tg-cynog-IP2758-Ab-1/ GM-Tg-cynog-IP2758-Ab-2;
GM-Tg-felg-IP2758-Ab-1/ GM-Tg-felg-IP2758-Ab-2; GM-Tg-cang-IP2758-Ab-1/ GM-Tg-cang-IP2758-Ab-2;
GM-Tg-bovg-IP2758-Ab-1/ GM-Tg-bovg-IP2758-Ab-2; GM-Tg-equg-IP2758-Ab-1/ GM-Tg-equg-IP2758-Ab-2
Products NameAnti-STIL monoclonal antibody
Formatmab
Target NameSTIL
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-STIL monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2758-Ag-1Recombinant multi-species STIL/ MCPH7/ SIL protein


    Target information

    Target IDGM-IP2758
    Target NameSTIL
    Gene ID6491,20460,313506,710099,610305,101097659,510012,100051410
    Gene Symbol and SynonymsMCPH7,SIL,STIL
    Uniprot AccessionQ15468
    Uniprot Entry NameSTIL_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000123473
    Target ClassificationTumor-associated antigen (TAA)

    The target: STIL, gene name: STIL, also named as MCPH7, SIL. This gene encodes a cytoplasmic protein implicated in regulation of the mitotic spindle checkpoint, a regulatory pathway that monitors chromosome segregation during cell division to ensure the proper distribution of chromosomes to daughter cells. The protein is phosphorylated in mitosis and in response to activation of the spindle checkpoint, and disappears when cells transition to G1 phase. It interacts with a mitotic regulator, and its expression is required to efficiently activate the spindle checkpoint. It is proposed to regulate Cdc2 kinase activity during spindle checkpoint arrest. Chromosomal deletions that fuse this gene and the adjacent locus commonly occur in T cell leukemias, and are thought to arise through illegitimate V-(D)-J recombination events. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.